A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/192 (2006.01) A61K 9/51 (2006.01) A61P 35/00 (2006.01) A61K 47/48 (2006.01)
Patent
CA 2673133
Disclosed are methods of treating subjects having conditions related to angiogenesis including administering an effective amount of a polymeric Nanoparticle form of thyroid hormone antagonist to inhibit angiogenesis in the subject. Compositions of the polymeric forms of thyroid hormone, or thyroid hormone antagonists, are also disclosed.
La présente invention concerne les procédés de traitement des sujets avec des conditions associées à l'angiogénèse y compris l'administration d'une quantité effective d'une forme nanoparticulaire polymérique d'une agoniste, d'un agoniste partiel ou d'un antagoniste de l'hormone thyroïde pour promouvoir ou inhiber l'angiogénèse dans le sujet. Les compositions des formes polymériques de l'hormone thyroïde ou les analogues de l'hormone thyroïde sont également décrits.
Davis Paul J.
Mousa Shaker A.
Albany College Of Pharmacy
Albany College Of Pharmacy And Health Sciences
Clf Medical Technology Acceleration Program Inc.
Ordway Research Institute Inc.
Ridout & Maybee Llp
LandOfFree
Nanoparticle and polymer formulations for thyroid hormone... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nanoparticle and polymer formulations for thyroid hormone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanoparticle and polymer formulations for thyroid hormone... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1547267